<b>Results</b>: DNMT3B overexpression was linked to enhancer-associated chromatin activation rather than recurrent genetic mutation, particularly in CEBPA- and NPM1-mutant AML. The gene discussed is NPM1; the disease is acute myeloid leukemia.